FindTrial
Sign In

EFFECTS OF ANTIBACTERIAL DRUGS' CLINICAL APPLICATION CONTROL ON PREMATURE INFANTS' BLOODSTREAM INFECTIONS

EFFECTS OF ANTIBACTERIAL DRUGS' CLINICAL APPLICATION CONTROL ON PREMATURE INFANTS' BLOODSTREAM INFECTIONS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-14005449
Enrollment
Unknown
Registered
2014-11-05
Start date
2014-11-05
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PREMATURE INFANTS' BLOODSTREAM INFECTIONS

Interventions

pre-control group:Before the antibacterial drugs' clinical application control
transition group:During the antibacterial drugs' clinical application control
post-control gruop :After the antibacterial drugs' clinical application control

Sponsors

Department of Neonatology, Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: All the patients who admitted to Children's Hospital of Chongqing Medical University in 2010, 2011, 2012, 2013 and 2014, and diagosed with neonatal sepsis or purulent meningitis or acute hematogenous osteomyelitis would be research objects.

Exclusion criteria

Exclusion criteria: The patients who do not accord with diagnostic criterias of neonatal sepsis or purulent meningitis or acute hematogenous osteomyelitis, based on the researchers' analysis.

Design outcomes

Primary

MeasureTime frame
Utilization rate of antibacterial drugs;antibiotic use density;The times antibacterial dru-gs being changed;—

Countries

China

Contacts

Public ContactHUA Zi-yu
h_ziyu@163.com+86 023-63633041

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026